Received Jun 19, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| FLU3 | INFLUENZA (SEASONAL) (FLUCELVAX) | SEQIRUS, INC. | 1 | 946639 | IM / RA |
Shortly after this vaccine (within the week) , the patient had to be put on an inhaler again after 25 years and placed on steroids. This was the first time in 25 years the patient had a respiratory attack. The patients immune system has been hyper reactive since, easily having respiratory/asthma attacks triggered, despite being put on steroids multiple times. This patient has not had a medical condition prior to this in the time period mentioned above before this vaccine was administered. Recently, she has been really close to calling EMS due to this repository attacks causing hypoxia. All the above is what is promoting this VAERS report, as many adverse effects by these vaccines are underreported.
no
no
none until after this vaccination
none known prior to vaccination
pulmonary function test